Literature DB >> 25113637

Influence of the microbiota on vaccine effectiveness.

Yanet Valdez1, Eric M Brown2, B Brett Finlay3.   

Abstract

Studies of the relationship between the microbiome and the development and function of the immune system are demonstrating novel concepts that could significantly alter the way we treat disease and promote wellness. Several diseases, including inflammatory bowel disease, allergy/asthma, and diabetes, are associated with changes in composition of the microbiome. Recent findings suggest novel complex mechanisms by which the microbiome impacts immune cell development and differentiation. A major implication of these findings is that the composition of microbiome may ultimately affect vaccine efficacy. We explore here the potential role of the microbiome in vaccine responses in the context of our growing understanding of the relationship between the gastrointestinal microbiota, resident immune cell populations, and systemic immunity.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  immune system; malnutrition; microbiota; probiotics; vaccines

Mesh:

Substances:

Year:  2014        PMID: 25113637     DOI: 10.1016/j.it.2014.07.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  62 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine.

Authors:  Evan J Anderson; Benjamin Lopman; Jumi Yi; Romina Libster; C Buddy Creech; Jill El-Khorazaty; Shahida Baqar; Inci Yildirim; Carol Kao; Nadine Rouphael; Andi L Shane; Kathryn Edwards
Journal:  J Pediatric Infect Dis Soc       Date:  2020-09-17       Impact factor: 3.164

Review 3.  Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.

Authors:  Glenn R Gibson; Robert Hutkins; Mary Ellen Sanders; Susan L Prescott; Raylene A Reimer; Seppo J Salminen; Karen Scott; Catherine Stanton; Kelly S Swanson; Patrice D Cani; Kristin Verbeke; Gregor Reid
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-06-14       Impact factor: 46.802

Review 4.  Homeostatic Immunity and the Microbiota.

Authors:  Yasmine Belkaid; Oliver J Harrison
Journal:  Immunity       Date:  2017-04-18       Impact factor: 31.745

Review 5.  What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Consideration of Strategies to Improve the Value of Animal Models.

Authors:  Ramin Sedaghat Herati; E John Wherry
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 6.  Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.

Authors:  Angelo A Izzo
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

7.  Toll-like receptor distribution in colonic epithelium and lamina propria is disrupted in HIV viremic, immune success, and failure.

Authors:  Marie R McCausland; Angélica Cruz-Lebrón; Heather A Pilch-Cooper; Scott Howell; Jeffrey M Albert; Young S Park; Alan D Levine
Journal:  AIDS       Date:  2020-05-01       Impact factor: 4.177

Review 8.  Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden.

Authors:  Abdullah Mahmud-Al-Rafat; Abdul Muktadir; Hasneen Muktadir; Mahbubul Karim; Arpan Maheshwari; Mohammad Mainul Ahasan
Journal:  Infection       Date:  2017-10-19       Impact factor: 3.553

Review 9.  Regulation of inflammation by microbiota interactions with the host.

Authors:  J Magarian Blander; Randy S Longman; Iliyan D Iliev; Gregory F Sonnenberg; David Artis
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 10.  The potential of the microbiota to influence vaccine responses.

Authors:  David J Lynn; Bali Pulendran
Journal:  J Leukoc Biol       Date:  2017-12-28       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.